VRS
OREX

Virginia Retirement Systems’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Virginia Retirement Systems’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,240
Closed -$386K – 1036
2014
Q2 		$386K Buy
+6,240
New +$363K 0.01% 748

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Virginia Retirement Systems's OREX Position: Q3 2014 in Review

Virginia Retirement Systems sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2014, closing a stake of 6,240 shares — an estimated $386K sold.

Virginia Retirement Systems first reported a position in OREX in Q2 2014 and held it in 1 quarter. The position peaked at $386K in Q2 2014. 128 funds tracked by Wall St. Rank hold OREX as of Q3 2014.

  • Virginia Retirement Systems reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • Virginia Retirement Systems sold 6,240 Orexigen Therapeutics, Inc. shares in Q3 2014, an estimated $386K.
  • Virginia Retirement Systems first reported a position in Orexigen Therapeutics, Inc. in Q2 2014 and held it in 1 quarter.
  • Virginia Retirement Systems's Orexigen Therapeutics, Inc. position peaked at $386K in Q2 2014.
  • 128 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2014.

Based on Virginia Retirement Systems's 13F filing for Q3 2014, filed 31 Oct 2014.